Public Market Listing
4151TSE
Live quotes, historical charts, and market capitalization for Kyowa Kirin are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(6 total)
6Total Assets
2Approved
1Phase 3 / Filed
3Phase 1–2 / Early
5Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
istradefylline(Nourianz) | Approved | adenosine A2ASmall molecule | Parkinson's Disease |
Saxagliptin(Onglyza) | Approved | DPP-4Small molecule | Type 2 Diabetes |
RTA 402No recent activity | Phase 3 | KEAP1/NRF2Small molecule | Type 2 Diabetes |
| Phase 1 | EpCAM (CD326) / CD40Small molecule | Non-Small Cell Lung Cancer | |
| Phase 1 | TIM-3 | Acute Myeloid Leukemia | |
| Phase 1 | Undisclosed / early pipelineBiologic (subtype unspecified) | Hypertension |
Upcoming events
Research
Unlock the company readout calendar
Research includes estimated primary-completion dates, earnings report dates, and 'What to watch' trial analysis across this company’s pipeline.
Financial reports
Research
Unlock sourced financial history
Research includes quarterly, interim and annual revenue, R&D, cash and burn figures linked to the underlying company reports.